Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Exposure to bisphenol A in European women from 2007 to 2014 using human biomonitoring data - The European Joint Programme HBM4EU

  • Tagne-Fotso, Romuald
  • Montazeri, Parisa, 1988-
  • Urquiza, José M.
  • Vrijheid, Martine
  • Rambaud, Loïc
Background: Bisphenol A (BPA; or 4,4'-isopropylidenediphenol) is an endocrine disrupting chemical. It was widely used in a variety of plastic-based manufactured products for several years. The European Food Safety Authority (EFSA) recently reduced the Tolerable Daily Intake (TDI) for BPA by 20,000 times due to concerns about immune-toxicity. Objective: We used human biomonitoring (HBM) data to investigate the general level of BPA exposure from 2007 to 2014 of European women aged 18-73 years (n = 4,226) and its determinants. Methods: Fifteen studies from 12 countries (Austria, Belgium, Denmark, France, Germany, Greece, Israel, Luxembourg, Slovenia, Spain, Sweden, and the United Kingdom) were included in the BPA Study protocol developed within the European Joint Programme HBM4EU. Seventy variables related to the BPA exposure were collected through a rigorous post-harmonization process. Linear mixed regression models were used to investigate the determinants of total urine BPA in the combined population. Results: Total BPA was quantified in 85-100 % of women in 14 out of 15 contributing studies. Only the Austrian PBAT study (Western Europe), which had a limit of quantification 2.5 to 25-fold higher than the other studies (LOQ=2.5 µg/L), found total BPA in less than 5 % of the urine samples analyzed. The geometric mean (GM) of total urine BPA ranged from 0.77 to 2.47 µg/L among the contributing studies. The lowest GM of total BPA was observed in France (Western Europe) from the ELFE subset (GM=0.77 µg/L (0.98 µg/g creatinine), n = 1741), and the highest levels were found in Belgium (Western Europe) and Greece (Southern Europe), from DEMOCOPHES (GM=2.47 µg/L (2.26 µg/g creatinine), n = 129) and HELIX-RHEA (GM=2.47 µg/L (2.44 µg/g creatinine), n = 194) subsets, respectively. One hundred percent of women in 14 out of 15 data collections in this study exceeded the health-based human biomonitoring guidance value for the general population (HBM-GVGenPop) of 0.0115 µg total BPA/L urine derived from the updated EFSA's BPA TDI. Variables related to the measurement of total urine BPA and those related to the main socio-demographic characteristics (age, height, weight, education, smoking status) were collected in almost all studies, while several variables related to BPA exposure factors were not gathered in most of the original studies (consumption of beverages contained in plastic bottles, consumption of canned food or beverages, consumption of food in contact with plastic packaging, use of plastic film or plastic containers for food, having a plastic floor covering in the house, use of thermal paper…). No clear determinants of total urine BPA concentrations among European women were found. A broader range of data planned for collection in the original questionnaires of the contributing studies would have resulted in a more thorough investigation of the determinants of BPA exposure in European women. Conclusion: This study highlights the urgent need for action to further reduce exposure to BPA to protect the population, as is already the case in the European Union. The study also underscores the importance of pre-harmonizing HBM design and data for producing comparable data and interpretable results at a European-wide level, and to increase HBM uptake by regulatory agencies., This study was a part of the HBM4EU project receiving funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 733032. Born in Bradford is funded from a variety of sources including A Wellcome Trust infrastructure grant (WT101597MA), a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC): MR/N024391/1; The British Heart Foundation (BHF) (CS/16/4/32482); The National Institute for Health and Care Research under its Applied Research Collaboration for Yorkshire and Humber NIHR200166; the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement 308333–the HELIX project. The views expressed in this publication are those of the author(s) and not necessarily those of the National Institute for Health and Care Research or the Department of Health and Social Care. DEMOCOPHES running in 2011–2012 was funded by the 7th European Union program (DG Research – No. 244237-COPHES), with a LIFE+2009 'Policy and governance' (DG Environment – LIFE09/ENV/BE/000410-DEMOCOPHES), with additional co-funding from DEMOCOPHES partners. The Belgian DEMOCOPHES study was co-financed by the Ministers of Environment and Health. It was coordinated by the Federal public service for health, food chain safety and environment (FOD) and followed up by the Belgian Cell Environment and Health including all federal, Flemish, Walloon and Brussels governmental entities working on Health and Environment. The Danish DEMOCOPHES study from 2011 to 2012 was co-financed by the Danish ministries of health, environment and food safety. The contribution of Luxembourg to DEMOCOPHES from 2011 to 2012 was co-financed by Luxembourg Institute of Science and Technology (LIST). The Slovenian DEMOCOPHES study was co-funded by the Slovenian Research Agency program P-0143. DEMOCOPHES in Spain was co-funded by the Spanish Ministry of Agricultures, Food and Environmental and the Instituto de Salud Carlos III (SEG 1251/07 and SEG 1112/10). The German ESB is funded by the Federal Ministry for the Environment, Nature Conservation, Nuclear Safety and Consumer Protection. The Israeli IBS study was supported by Research Grant Award No. RGA 902 from the Environment and Health Fund, Jerusalem, Israel. The Austrian PBAT study was partially financed by the former Austrian Federal Ministry of Agriculture, Forestry, Environment and Water Management and by the Environment Agency Austria. Samples were provided from the Austrian Study of Nutritional Status 2012, which was funded by the former Austrian Federal Ministry of Health. The French human biomonitoring program, of which the ELFE cohort was a component, was funded by the French Ministries of Health and the Environment. ELFE benefited from additional funding from the Ministry of Research, Committee on SHS data (CCDSHS) and Ministry of Culture and Communication (Deps), and as part of the RECONAI platform, from National Research Agency funding (ANR-11-EQPX-0038).
Repisalud
Publication Artículo científico (JournalArticle)

A pilot study on the feasibility of European harmonized human biomonitoring: Strategies towards a common approach, challenges and opportunities

  • Casteleyn, L
  • Dumez, B
  • Becker, K
  • Kolossa-Gehring, Marike
  • Den Hond, Elly
  • Schoeters, G
  • Castaño, Argelia
  • Koch, Holger M
  • Angerer, J
  • Esteban-Lopez, Marta
  • Exley, K
  • Sepai, O
  • Bloemen, L
  • Horvat, M
  • Knudsen, L E
  • Joas, A
  • Joas, R
  • Biot, P
  • Koppen, G
  • Dewolf, M-C
  • Katsonouri, A
  • Hadjipanayis, A
  • Černá, Milena
  • Krskova, Andrea
  • Schwedler, G
  • Fiddicke, U
  • Nielsen, J K S
  • Jensen, J F
  • Rudnai, P
  • Közepésy, S
  • Mulcahy, M
  • Mannion, R
  • Gutleb, A C
  • Fischer, M E
  • Ligocka, D
  • Jakubowski, M
  • Reis, M F
  • Namorado, Sónia
  • Lupsa, I-R
  • Gurzau, Anca Elena
  • Halzlova, K
  • Jajcaj, M
  • Mazej, D
  • Tratnik Snoj, J
  • Posada De la Paz, Manuel
  • Lopez-Martin, Estrella
  • Berglund, M
  • Larsson, K
  • Lehmann, A
  • Crettaz, P
  • Aerts, D
In 2004 the European Commission and Member States initiated activities towards a harmonized approach for Human Biomonitoring surveys throughout Europe. The main objective was to sustain environmental health policy by building a coherent and sustainable framework and by increasing the comparability of data across countries. A pilot study to test common guidelines for setting up surveys was considered a key step in this process. Through a bottom-up approach that included all stakeholders, a joint study protocol was elaborated. From September 2011 till February 2012, 17 European countries collected data from 1844 mother-child pairs in the frame of DEMOnstration of a study to COordinate and Perform Human Biomonitoring on a European Scale (DEMOCOPHES).(1) Mercury in hair and urinary cadmium and cotinine were selected as biomarkers of exposure covered by sufficient analytical experience. Phthalate metabolites and Bisphenol A in urine were added to take into account increasing public and political awareness for emerging types of contaminants and to test less advanced markers/markers covered by less analytical experience. Extensive efforts towards chemo-analytical comparability were included. The pilot study showed that common approaches can be found in a context of considerable differences with respect to experience and expertize, socio-cultural background, economic situation and national priorities. It also evidenced that comparable Human Biomonitoring results can be obtained in such context. A European network was built, exchanging information, expertize and experiences, and providing training on all aspects of a survey. A key challenge was finding the right balance between a rigid structure allowing maximal comparability and a flexible approach increasing feasibility and capacity building. Next steps in European harmonization in Human Biomonitoring surveys include the establishment of a joint process for prioritization of substances to cover and biomarkers to develop, linking biomonitoring surveys with health examination surveys and with research, and coping with the diverse implementations of EU regulations and international guidelines with respect to ethics and privacy.
Repisalud
Publication Artículo científico (JournalArticle)

Fish consumption patterns and hair mercury levels in children and their mothers in 17 EU countries

  • Castaño, Argelia
  • Cutanda, Francisco
  • Esteban-Lopez, Marta
  • Pärt, Peter
  • Navarro Rivas, Carmen
  • Gomez Perez, Silvia
  • Rosado, Montserrat
  • Lopez-Herranz, Ana
  • Lopez-Martin, Estrella
  • Exley, Karen
  • Schindler, Birgit K
  • Govarts, Eva
  • Casteleyn, Ludwine
  • Kolossa-Gehring, Marike
  • Fiddicke, Ulrike
  • Koch, Holger M
  • Angerer, Jürgen
  • Den Hond, Elly
  • Schoeters, Greet
  • Sepai, Ovnair
  • Horvat, Milena
  • Knudsen, Lisbeth E
  • Aerts, Dominique
  • Joas, Anke
  • Biot, Pierre
  • Joas, Reinhard
  • Jiménez-Guerrero, José A
  • Diaz-Lopez, Gema
  • Pirard, Catherine
  • Katsonouri, Andromachi
  • Černá, Milena
  • Gutleb, Arno C
  • Ligocka, Danuta
  • Reis, Fátima M
  • Berglund, Marika
  • Lupsa, Ioana-Rodica
  • Halzlova, Katarina
  • Charlier, Corinne
  • Cullen, Elizabeth
  • Hadjipanayis, Adamos
  • Krskova, Andrea
  • Jensen, Janne F
  • Nielsen, Jeanette K
  • Schwedler, Gerda
  • Wilhelm, Michael
  • Rudnai, Peter
  • Középesy, Szilvia
  • Davidson, Fred
  • Fischer, Mark E
  • Janasik, Beata
  • Namorado, Sónia
  • Gurzau, Anca Elena
  • Jajcaj, Michal
  • Mazej, Darja
  • Tratnik, Janja Snoj
  • Larsson, Kristin
  • Lehmann, Andrea
  • Crettaz, Pierre
  • Lavranos, Giagkos
  • Posada De la Paz, Manuel
The toxicity of methylmercury (MeHg) in humans is well established and the main source of exposure is via the consumption of large marine fish and mammals. Of particular concern are the potential neurodevelopmental effects of early life exposure to low-levels of MeHg. Therefore, it is important that pregnant women, children and women of childbearing age are, as far as possible, protected from MeHg exposure. Within the European project DEMOCOPHES, we have analyzed mercury (Hg) in hair in 1799 mother-child pairs from 17 European countries using a strictly harmonized protocol for mercury analysis. Parallel, harmonized questionnaires on dietary habits provided information on consumption patterns of fish and marine products. After hierarchical cluster analysis of consumption habits of the mother-child pairs, the DEMOCOPHES cohort can be classified into two branches of approximately similar size: one with high fish consumption (H) and another with low consumption (L). All countries have representatives in both branches, but Belgium, Denmark, Spain, Portugal and Sweden have twice as many or more mother-child pairs in H than in L. For Switzerland, Czech Republic, Hungary, Poland, Romania, Slovenia and Slovakia the situation is the opposite, with more representatives in L than H. There is a strong correlation (r=0.72) in hair mercury concentration between the mother and child in the same family, which indicates that they have a similar exposure situation. The clustering of mother-child pairs on basis of their fish consumption revealed some interesting patterns. One is that for the same sea fish consumption, other food items of marine origin, like seafood products or shellfish, contribute significantly to the mercury levels in hair. We conclude that additional studies are needed to assess and quantify exposure to mercury from seafood products, in particular. The cluster analysis also showed that 95% of mothers who consume once per week fish only, and no other marine products, have mercury levels 0.55 μg/g. Thus, the 95th percentile of the distribution in this group is only around half the US-EPA recommended threshold of 1 μg/g mercury in hair. Consumption of freshwater fish played a minor role in contributing to mercury exposure in the studied cohort. The DEMOCOPHES data shows that there are significant differences in MeHg exposure across the EU and that exposure is highly correlated with consumption of fish and marine products. Fish and marine products are key components of a healthy human diet and are important both traditionally and culturally in many parts of Europe. Therefore, the communication of the potential risks of mercury exposure needs to be carefully balanced to take into account traditional and cultural values as well as the potential health benefits from fish consumption. European harmonized human biomonitoring programs provide an additional dimension to national HMB programs and can assist national authorities to tailor mitigation and adaptation strategies (dietary advice, risk communication, etc.) to their country's specific requirements.
Repisalud
Publication Artículo científico (JournalArticle)

Exposure determinants of cadmium in European mothers and their children

  • Berglund, Marika
  • Larsson, Kristin
  • Grandér, Margaretha
  • Casteleyn, Ludwine
  • Kolossa-Gehring, Marike
  • Schwedler, Gerda
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Angerer, Jürgen
  • Koch, Holger M
  • Schindler, Birgit K
  • Schoeters, Greet
  • Smolders, Roel
  • Exley, Karen
  • Sepai, Ovnair
  • Blumen, Luies
  • Horvat, Milena
  • Knudsen, Lisbeth E
  • Mørck, Thit A
  • Joas, Anke
  • Joas, Reinhard
  • Biot, Pierre
  • Aerts, Dominique
  • De Cremer, Koen
  • Van Overmeire, Ilse
  • Katsonouri, Andromachi
  • Hadjipanayis, Adamos
  • Černá, Milena
  • Krskova, Andrea
  • Nielsen, Jeanette K S
  • Jensen, Janne Fangel
  • Rudnai, Peter
  • Középesy, Szilvia
  • Griffin, Chris
  • Nesbitt, Ian
  • Gutleb, Arno C
  • Fischer, Marc E
  • Ligocka, Danuta
  • Jakubowski, Marek
  • Reis, M Fátima
  • Namorado, Sónia
  • Lupsa, Ioana-Rodica
  • Gurzau, Anca Elena
  • Halzlova, Katarina
  • Jajcaj, Michal
  • Mazej, Darja
  • Tratnik, Janja Snoj
  • Lopez-Herranz, Ana
  • Cañas Portilla, Ana Isabel
  • Lehmann, Andrea
  • Crettaz, Pierre
  • Den Hond, Elly
  • Govarts, Eva
The metal cadmium (Cd) is a widespread environmental pollutant with documented adverse effects on the kidneys and bones from long-term environmental exposure, but with insufficiently elucidated public health consequences such as risk of cardiovascular disease, hormone-related cancer in adults and developmental effects in children. This study is the first pan-European human biomonitoring project that succeeded in performing harmonized measurements of Cd in urine in a comparable way in mother-child couples from 16 European countries. The aim of the study was to evaluate the overall Cd exposure and significant determinants of Cd exposure. A study population of 1632 women (24-52 years of age), and 1689 children (5-12 years of age), from 32 rural and urban areas, was examined within a core period of 6 months in 2011-2012. Women were stratified as smokers and non-smokers. As expected, smoking mothers had higher geometric mean (gm) urinary cadmium (UCd; 0.24 µg/g crea; n=360) than non-smoking mothers (gm 0.18 µg/g crea; n=1272; p<0.0001), and children had lower UCd (gm 0.065 µg/g crea; n=1689) than their mothers at the country level. Non-smoking women exposed to environmental tobacco smoke (ETS) at home had 14% (95% CI 1-28%) higher UCd than those who were not exposed to ETS at home (p=0.04). No influence of ETS at home or other places on UCd levels was detected in children. Smoking women with primary education as the highest educational level of the household had 48% (95% CI 18-86%) higher UCd than those with tertiary education (p=0.0008). The same observation was seen in non-smoking women and in children; however they were not statistically significant. In children, living in a rural area was associated with 7% (95% CI 1-13%) higher UCd (p=0.03) compared to living in an urban area. Children, 9-12 years had 7% (95% CI 1-13%) higher UCd (p=0.04) than children 5-8 years. About 1% of the mothers, and 0.06% of the children, exceeded the tolerable weekly intake (TWI) appointed by EFSA, corresponding to 1.0 µg Cd/g crea in urine. Poland had the highest UCd in comparison between the 16 countries, while Denmark had the lowest. Whether the differences between countries are related to differences in the degree of environmental Cd contamination or to differences in lifestyle, socioeconomic status or dietary patterns is not clear.
Repisalud
Publication Artículo científico (JournalArticle)

Mercury exposure in Ireland: results of the DEMOCOPHES human biomonitoring study

  • Cullen, Elizabeth
  • Evans, David S
  • Davidson, Fred
  • Burke, Padraig
  • Burns, Damien
  • Flanagan, Andrew
  • Griffin, Chris
  • Kellegher, Anne
  • Mannion, Rory
  • Mulcahy, Maurice
  • Ryan, Michael
  • Biot, Pierre
  • Casteleyn, Ludwine
  • Castaño, Argelia
  • Angerer, Jürgen
  • Koch, Holger M
  • Esteban-Lopez, Marta
  • Schindler, Birgit K
  • Navarro Rivas, Carmen
  • Kolossa-Gehring, Marike
  • Fiddicke, Ulrike
  • Schoeters, Greet
  • Hond, Elly Den
  • Sepai, Ovnair
  • Exley, Karen
  • Bloemen, Louis
  • Knudsen, Lisbeth E
  • Joas, Reinhard
  • Joas, Anke
  • Aerts, Dominique
Background: Monitoring of human exposure to mercury is important due to its adverse health effects. This study aimed to determine the extent of mercury exposure among mothers and their children in Ireland, and to identify factors associated with elevated levels. It formed part of the Demonstration of a study to Coordinate and Perform Human Biomonitoring on a European Scale (DEMOCOPHES) pilot biomonitoring study. Methods: Hair mercury concentrations were determined from a convenience sample of 120 mother/child pairs. Mothers also completed a questionnaire. Rigorous quality assurance within DEMOCOPHES guaranteed the accuracy and international comparability of results. Results: Mercury was detected in 79.2% of the samples from mothers, and 62.5% of children's samples. Arithmetic mean levels in mothers (0.262 µg/g hair) and children (0.149 µg /g hair) did not exceed the US EPA guidance value. Levels were significantly higher for those with higher education, and those who consumed more fish. Conclusions: The study demonstrates the benefit of human biomonitoring for assessing and comparing internal exposure levels, both on a population and an individual basis. It enables the potential harmful impact of mercury to be minimised in those highly exposed, and can therefore significantly contribute to population health.
Repisalud
Publication Artículo científico (JournalArticle)

The Danish contribution to the European DEMOCOPHES project: A description of cadmium, cotinine and mercury levels in Danish mother-child pairs and the perspectives of supplementary sampling and measurements

  • Mørck, Thit A
  • Nielsen, Flemming
  • Nielsen, Jeanette K S
  • Jensen, Janne F
  • Hansen, Pernille W
  • Hansen, Anne K
  • Christoffersen, Lea N
  • Siersma, Volkert D
  • Larsen, Ida H
  • Hohlmann, Linette K
  • Skaanild, Mette T
  • Frederiksen, Hanne
  • Biot, Pierre
  • Casteleyn, Ludwine
  • Kolossa-Gehring, Marike
  • Schwedler, Gerda
  • Castaño, Argelia
  • Angerer, Jürgen
  • Koch, Holger M
  • Esteban-Lopez, Marta
  • Schoeters, Greet
  • Den Hond, Elly
  • Exley, Karen
  • Sepai, Ovnair
  • Bloemen, Louis
  • Joas, Reinhard
  • Joas, Anke
  • Fiddicke, Ulrike
  • Lopez-Herranz, Ana
  • Cañas Portilla, Ana Isabel
  • Aerts, Dominique
  • Knudsen, Lisbeth E
Human biomonitoring (HBM) is an important tool, increasingly used for measuring true levels of the body burdens of environmental chemicals in the general population. In Europe, a harmonized HBM program was needed to open the possibility to compare levels across borders. To explore the prospect of a harmonized European HBM project, DEMOCOPHES (DEMOnstration of a study to COordinate and Perform Human biomonitoring on a European Scale) was completed in 17 European countries. The basic measurements performed in all implemented countries of DEMOCOPHES included cadmium, cotinine and phthalate metabolites in urine and mercury in hair. In the Danish participants, significant correlations between mothers and children for mercury in hair and cotinine in urine were found. Mercury in hair was further significantly associated with intake of fish and area of residence. Cadmium was positively associated with BMI in mothers and an association between cadmium and cotinine was also found. As expected high cotinine levels were found in smoking mothers. For both mercury and cadmium significantly higher concentrations were found in the mothers compared to their children. In Denmark, the DEMOCOPHES project was co-financed by the Danish ministries of health, environment and food safety. The co-financing ministries agreed to finance a number of supplementary measurements of substances of current toxicological, public and regulatory interest. This also included blood sampling from the participants. The collected urine and blood samples were analyzed for a range of other persistent and non-persistent environmental chemicals as well as two biomarkers of effect. The variety of supplementary measurements gives the researchers further information on the exposure status of the participants and creates a basis for valuable knowledge on the pattern of exposure to various chemicals.
Repisalud
Publication Artículo científico (JournalArticle)

DEMOCOPHES España y su contribución a la armonización de la biovigilancia humana en Europa, DEMOCOPHES Spain and its contribution to the harmonization of Europe an human biomonitoring

  • Esteban-Lopez, Marta
  • Lopez-Martin, Estrella
  • Rodríguez García, Carolina
  • Posada De la Paz, Manuel
  • Castaño, Argelia
[ES] Objetivo: contribuir a la armonización europea de la biovigilancia en humanos (proyecto DEMOCOPHES) demostrando la utilidad de los estudios de biovigilancia para valorar la influencia de la dieta y los estilos de vida como vía de exposición a contaminantes ambientales. Métodos: se adaptó el protocolo europeo a las necesidades nacionales, siguiendo los controles de calidad definidos en él y sin comprometer la obtención de datos comparables entre los países participantes. Resultados: la adaptación nacional del protocolo europeo no presentó grandes dificultades y, salvo mínimas modificaciones, se respetó el diseño original del estudio. Participaron 134 parejas madre-hijo, seleccionados en un colegio de Añover de Tajo (Toledo) y tres colegios de Madrid. Los voluntarios donaron una muestra de pelo y de orina y contestaron a las preguntas del cuestionario epidemiológico. Se observaron diferencias significativas en la participación de los voluntarios en las dos localizaciones de muestreo. Discusión: la estandarización de todas las etapas de un estudio de biovigilancia en humanos es esencial para su desarrollo armonizado a escala internacional. Los resultados obtenidos han contribuido a la obtención de datos sobre exposición ambiental, por primera vez comparables en 17 países europeos, y han permitido observar diferencias relacionadas con la dieta y los hábitos de vida. Las experiencias y el material de trabajo desarrollado para el estudio piloto serán aplicables al diseño e implementación de futuros estudios de HBM. [EN] Objetive: contributing to demonstrate of the feasibility of a coordinated action on human biomonitoring in Europe (DEMOCOPHES project) and demonstrate the utility of HBM studies to assess the influence of diet and lifestyle in environmental exposures. Methods: the EU protocol was adapted to the national requirements. The quality controls defined herein were followed and special care was taken to ensure the comparability of the results among participating countries. Results: the protocol adaptation did not shown significant difficulties. Only minor changes were applied, so the original design of the study was respected. 134 mother- child pairs were selected in one school in Añover de Tajo (Toledo) and three schools in Madrid. All volunteers donated a urine and hair sample and complete the epidemiological questionnaire. Significant differences were found in the participation rates between the sampling locations. Discussion: standardization of all steps in a human biomonitoring study is essential for its harmonized development in Europe. The results has contributed to obtain for the first time comparable data about environmental exposure in the general population within 17 EU countries showing the differences associated with diet and lifestyles. The experiences and materials developed in the fieldwork could be applied to the design and implementation of HBM studies in the future.
Repisalud
Publication Artículo científico (JournalArticle)

Exposure to bisphenol A in European women from 2007 to 2014 using human biomonitoring data - The European Joint Programme HBM4EU

  • Tagne-Fotso, Romuald
  • Riou, Margaux
  • Saoudi, Abdessattar
  • Zeghnoun, Abdelkrim
  • Frederiksen, Hanne
  • Berman, Tamar
  • Montazeri, Parisa
  • Andersson, Anna-Maria
  • Rodriguez-Martin, Laura
  • Åkesson, Agneta
  • Berglund, Marika
  • Biot, Pierre
  • Castaño, Argelia
  • Charles, Marie-Aline
  • Cocco, Emmanuelle
  • Den Hond, Elly
  • Dewolf, Marie-Christine
  • Esteban-Lopez, Marta
  • Gilles, Liese
  • Govarts, Eva
  • Guignard, Cedric
  • Gutleb, Arno C
  • Hartmann, Christina
  • Kold Jensen, Tina
  • Koppen, Gudrun
  • Kosjek, Tina
  • Lambrechts, Nathalie
  • McEachan, Rosemary
  • Sakhi, Amrit K
  • Snoj Tratnik, Janja
  • Uhl, Maria
  • Urquiza, Jose
  • Vafeiadi, Marina
  • Van Nieuwenhuyse, An
  • Vrijheid, Martine
  • Weber, Till
  • Zaros, Cécile
  • Tarroja-Aulina, Elena
  • Knudsen, Lisbeth E
  • Covaci, Adrian
  • Barouki, Robert
  • Kolossa-Gehring, Marike
  • Schoeters, Greet
  • Denys, Sebastien
  • Fillol, Clémence
  • Rambaud, Loïc
Background: Bisphenol A (BPA; or 4,4'-isopropylidenediphenol) is an endocrine disrupting chemical. It was widely used in a variety of plastic-based manufactured products for several years. The European Food Safety Authority (EFSA) recently reduced the Tolerable Daily Intake (TDI) for BPA by 20,000 times due to concerns about immune-toxicity. Objective: We used human biomonitoring (HBM) data to investigate the general level of BPA exposure from 2007 to 2014 of European women aged 18-73 years (n = 4,226) and its determinants. Methods: Fifteen studies from 12 countries (Austria, Belgium, Denmark, France, Germany, Greece, Israel, Luxembourg, Slovenia, Spain, Sweden, and the United Kingdom) were included in the BPA Study protocol developed within the European Joint Programme HBM4EU. Seventy variables related to the BPA exposure were collected through a rigorous post-harmonization process. Linear mixed regression models were used to investigate the determinants of total urine BPA in the combined population. Results: Total BPA was quantified in 85-100 % of women in 14 out of 15 contributing studies. Only the Austrian PBAT study (Western Europe), which had a limit of quantification 2.5 to 25-fold higher than the other studies (LOQ=2.5 µg/L), found total BPA in less than 5 % of the urine samples analyzed. The geometric mean (GM) of total urine BPA ranged from 0.77 to 2.47 µg/L among the contributing studies. The lowest GM of total BPA was observed in France (Western Europe) from the ELFE subset (GM=0.77 µg/L (0.98 µg/g creatinine), n = 1741), and the highest levels were found in Belgium (Western Europe) and Greece (Southern Europe), from DEMOCOPHES (GM=2.47 µg/L (2.26 µg/g creatinine), n = 129) and HELIX-RHEA (GM=2.47 µg/L (2.44 µg/g creatinine), n = 194) subsets, respectively. One hundred percent of women in 14 out of 15 data collections in this study exceeded the health-based human biomonitoring guidance value for the general population (HBM-GVGenPop) of 0.0115 µg total BPA/L urine derived from the updated EFSA's BPA TDI. Variables related to the measurement of total urine BPA and those related to the main socio-demographic characteristics (age, height, weight, education, smoking status) were collected in almost all studies, while several variables related to BPA exposure factors were not gathered in most of the original studies (consumption of beverages contained in plastic bottles, consumption of canned food or beverages, consumption of food in contact with plastic packaging, use of plastic film or plastic containers for food, having a plastic floor covering in the house, use of thermal paper…). No clear determinants of total urine BPA concentrations among European women were found. A broader range of data planned for collection in the original questionnaires of the contributing studies would have resulted in a more thorough investigation of the determinants of BPA exposure in European women. Conclusion: This study highlights the urgent need for action to further reduce exposure to BPA to protect the population, as is already the case in the European Union. The study also underscores the importance of pre-harmonizing HBM design and data for producing comparable data and interpretable results at a European-wide level, and to increase HBM uptake by regulatory agencies.
Repisalud
Publication Artículo científico (JournalArticle)

The European COPHES/DEMOCOPHES project: towards transnational comparability and reliability of human biomonitoring results

  • Schindler, Birgit Karin
  • Esteban-Lopez, Marta
  • Koch, Holger M
  • Castaño, Argelia
  • Koslitz, Stephan
  • Cañas, Ana
  • Casteleyn, Ludwine
  • Kolossa-Gehring, Marike
  • Schwedler, Gerda
  • Schoeters, Greet
  • Hond, Elly Den
  • Sepai, Ovnair
  • Exley, Karen
  • Bloemen, Louis
  • Horvat, Milena
  • Knudsen, Lisbeth E
  • Joas, Anke
  • Joas, Reinhard
  • Biot, Pierre
  • Aerts, Dominique
  • Lopez-Herranz, Ana
  • Huetos, Olga
  • Katsonouri, Andromachi
  • Maurer-Chronakis, Katja
  • Kasparova, Lucie
  • Vrbík, Karel
  • Rudnai, Peter
  • Naray, Miklos
  • Guignard, Cedric
  • Fischer, Marc E
  • Ligocka, Danuta
  • Janasik, Beata
  • Reis, M Fátima
  • Namorado, Sónia
  • Pop, Cristian
  • Dumitrascu, Irina
  • Halzlova, Katarina
  • Fabianova, Eleonora
  • Mazej, Darja
  • Tratnik, Janja Snoj
  • Berglund, Marika
  • Jönsson, Bo
  • Lehmann, Andrea
  • Crettaz, Pierre
  • Frederiksen, Hanne
  • Nielsen, Flemming
  • McGrath, Helena
  • Nesbitt, Ian
  • De Cremer, Koen
  • Vanermen, Guido
  • Koppen, Gudrun
  • Wilhelm, Michael
  • Becker, Kerstin
  • Angerer, Jürgen
COPHES/DEMOCOPHES has its origins in the European Environment and Health Action Plan of 2004 to "develop a coherent approach on human biomonitoring (HBM) in Europe". Within this twin-project it was targeted to collect specimens from 120 mother-child-pairs in each of the 17 participating European countries. These specimens were investigated for six biomarkers (mercury in hair; creatinine, cotinine, cadmium, phthalate metabolites and bisphenol A in urine). The results for mercury in hair are described in a separate paper. Each participating member state was requested to contract laboratories, for capacity building reasons ideally within its borders, carrying out the chemical analyses. To ensure comparability of analytical data a Quality Assurance Unit (QAU) was established which provided the participating laboratories with standard operating procedures (SOP) and with control material. This material was specially prepared from native, non-spiked, pooled urine samples and was tested for homogeneity and stability. Four external quality assessment exercises were carried out. Highly esteemed laboratories from all over the world served as reference laboratories. Web conferences after each external quality assessment exercise functioned as a new and effective tool to improve analytical performance, to build capacity and to educate less experienced laboratories. Of the 38 laboratories participating in the quality assurance exercises 14 laboratories qualified for cadmium, 14 for creatinine, 9 for cotinine, 7 for phthalate metabolites and 5 for bisphenol A in urine. In the last of the four external quality assessment exercises the laboratories that qualified for DEMOCOPHES performed the determinations in urine with relative standard deviations (low/high concentration) of 18.0/2.1% for cotinine, 14.8/5.1% for cadmium, 4.7/3.4% for creatinine. Relative standard deviations for the newly emerging biomarkers were higher, with values between 13.5 and 20.5% for bisphenol A and between 18.9 and 45.3% for the phthalate metabolites. Plausibility control of the HBM results of all participating countries disclosed analytical shortcomings in the determination of Cd when using certain ICP/MS methods. Results were corrected by reanalyzes. The COPHES/DEMOCOPHES project for the first time succeeded in performing a harmonized pan-European HBM project. All data raised have to be regarded as utmost reliable according to the highest international state of the art, since highly renowned laboratories functioned as reference laboratories. The procedure described here, that has shown its success, can be used as a blueprint for future transnational, multicentre HBM projects.
Repisalud
Publication Artículo científico (JournalArticle)

Human biomonitoring pilot study DEMOCOPHES in Germany: Contribution to a harmonized European approach

  • Schwedler, Gerda
  • Seiwert, Margarete
  • Fiddicke, Ulrike
  • Ißleb, Sissy
  • Hölzer, Jürgen
  • Nendza, Julia
  • Wilhelm, Michael
  • Wittsiepe, Jürgen
  • Koch, Holger M
  • Schindler, Birgit K
  • Göen, Thomas
  • Hildebrand, Jörg
  • Joas, Reinhard
  • Joas, Anke
  • Casteleyn, Ludwine
  • Angerer, Jürgen
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Schoeters, Greet
  • Den Hond, Elly
  • Sepai, Ovnair
  • Exley, Karen
  • Bloemen, Louis
  • Knudsen, Lisbeth E
  • Kolossa-Gehring, Marike
Human biomonitoring (HBM) is an effective tool to assess human exposure to environmental pollutants, but comparable HBM data in Europe are lacking. In order to expedite harmonization of HBM studies on a European scale, the twin projects COPHES (Consortium to Perform Human Biomonitoring on a European Scale) and DEMOCOPHES (Demonstration of a study to Coordinate and Perform Human Biomonitoring on a European Scale) were formed, comprising 35 partners from 27 European countries. In COPHES a research scheme and guidelines were developed to exemplarily measure in a pilot study mercury in hair, cadmium, cotinine and several phthalate metabolites in urine of 6-11year old children and their mothers in an urban and a rural region. Seventeen European countries simultaneously conducted this cross-sectional DEMOCOPHES feasibility study. The German study population was taken in the city of Bochum and in the Higher Sauerland District, comprising 120 mother-child pairs. In the present paper features of the study implementation are presented. German exposure concentrations of the pollutants are reported and compared with European average concentrations from DEMOCOPHES and with those measured in the representative German Environmental Survey (GerES IV). German DEMOCOPHES concentrations for mercury and cotinine were lower than the European average. However, 47% of the children were still exposed to environmental tobacco smoke (ETS) outside their home, which gives further potential for enhancing protection of children from ETS. Compared with samples from the other European countries German participating children had lower concentrations of the phthalate metabolites MEP and of the sum of 3 DEHP-metabolites (MEHP, 5OH-MEHP and 5oxo-MEHP), about the same concentrations of the phthalate metabolites MBzP and MiBP and higher concentrations of the phthalate metabolite MnBP. 2.5% of the German children had concentrations of the sum of 4 DEHP-metabolites and 4.2% had concentrations of MnBP that exceeded health based guidance values, indicating reasons for concern. Continuous HBM is necessary to track changes of pollutant exposure over time. Therefore Germany will continue to cooperate on the harmonisation of European human biomonitoring to support the chemicals regulation with the best possible exposure data to protect Europe's people against environmental health risks.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Exposure to bisphenol A in European women from 2007 to 2014 using human biomonitoring data - The European Joint Programme HBM4EU

  • Tagne-Fotso, Romuald
  • Montazeri, Parisa, 1988-
  • Urquiza, José M.
  • Vrijheid, Martine
  • Rambaud, Loïc
Background: Bisphenol A (BPA; or 4,4'-isopropylidenediphenol) is an endocrine disrupting chemical. It was widely used in a variety of plastic-based manufactured products for several years. The European Food Safety Authority (EFSA) recently reduced the Tolerable Daily Intake (TDI) for BPA by 20,000 times due to concerns about immune-toxicity. Objective: We used human biomonitoring (HBM) data to investigate the general level of BPA exposure from 2007 to 2014 of European women aged 18-73 years (n = 4,226) and its determinants. Methods: Fifteen studies from 12 countries (Austria, Belgium, Denmark, France, Germany, Greece, Israel, Luxembourg, Slovenia, Spain, Sweden, and the United Kingdom) were included in the BPA Study protocol developed within the European Joint Programme HBM4EU. Seventy variables related to the BPA exposure were collected through a rigorous post-harmonization process. Linear mixed regression models were used to investigate the determinants of total urine BPA in the combined population. Results: Total BPA was quantified in 85-100 % of women in 14 out of 15 contributing studies. Only the Austrian PBAT study (Western Europe), which had a limit of quantification 2.5 to 25-fold higher than the other studies (LOQ=2.5 µg/L), found total BPA in less than 5 % of the urine samples analyzed. The geometric mean (GM) of total urine BPA ranged from 0.77 to 2.47 µg/L among the contributing studies. The lowest GM of total BPA was observed in France (Western Europe) from the ELFE subset (GM=0.77 µg/L (0.98 µg/g creatinine), n = 1741), and the highest levels were found in Belgium (Western Europe) and Greece (Southern Europe), from DEMOCOPHES (GM=2.47 µg/L (2.26 µg/g creatinine), n = 129) and HELIX-RHEA (GM=2.47 µg/L (2.44 µg/g creatinine), n = 194) subsets, respectively. One hundred percent of women in 14 out of 15 data collections in this study exceeded the health-based human biomonitoring guidance value for the general population (HBM-GVGenPop) of 0.0115 µg total BPA/L urine derived from the updated EFSA's BPA TDI. Variables related to the measurement of total urine BPA and those related to the main socio-demographic characteristics (age, height, weight, education, smoking status) were collected in almost all studies, while several variables related to BPA exposure factors were not gathered in most of the original studies (consumption of beverages contained in plastic bottles, consumption of canned food or beverages, consumption of food in contact with plastic packaging, use of plastic film or plastic containers for food, having a plastic floor covering in the house, use of thermal paper…). No clear determinants of total urine BPA concentrations among European women were found. A broader range of data planned for collection in the original questionnaires of the contributing studies would have resulted in a more thorough investigation of the determinants of BPA exposure in European women. Conclusion: This study highlights the urgent need for action to further reduce exposure to BPA to protect the population, as is already the case in the European Union. The study also underscores the importance of pre-harmonizing HBM design and data for producing comparable data and interpretable results at a European-wide level, and to increase HBM uptake by regulatory agencies., This study was a part of the HBM4EU project receiving funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 733032. Born in Bradford is funded from a variety of sources including A Wellcome Trust infrastructure grant (WT101597MA), a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC): MR/N024391/1; The British Heart Foundation (BHF) (CS/16/4/32482); The National Institute for Health and Care Research under its Applied Research Collaboration for Yorkshire and Humber NIHR200166; the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement 308333–the HELIX project. The views expressed in this publication are those of the author(s) and not necessarily those of the National Institute for Health and Care Research or the Department of Health and Social Care. DEMOCOPHES running in 2011–2012 was funded by the 7th European Union program (DG Research – No. 244237-COPHES), with a LIFE+2009 'Policy and governance' (DG Environment – LIFE09/ENV/BE/000410-DEMOCOPHES), with additional co-funding from DEMOCOPHES partners. The Belgian DEMOCOPHES study was co-financed by the Ministers of Environment and Health. It was coordinated by the Federal public service for health, food chain safety and environment (FOD) and followed up by the Belgian Cell Environment and Health including all federal, Flemish, Walloon and Brussels governmental entities working on Health and Environment. The Danish DEMOCOPHES study from 2011 to 2012 was co-financed by the Danish ministries of health, environment and food safety. The contribution of Luxembourg to DEMOCOPHES from 2011 to 2012 was co-financed by Luxembourg Institute of Science and Technology (LIST). The Slovenian DEMOCOPHES study was co-funded by the Slovenian Research Agency program P-0143. DEMOCOPHES in Spain was co-funded by the Spanish Ministry of Agricultures, Food and Environmental and the Instituto de Salud Carlos III (SEG 1251/07 and SEG 1112/10). The German ESB is funded by the Federal Ministry for the Environment, Nature Conservation, Nuclear Safety and Consumer Protection. The Israeli IBS study was supported by Research Grant Award No. RGA 902 from the Environment and Health Fund, Jerusalem, Israel. The Austrian PBAT study was partially financed by the former Austrian Federal Ministry of Agriculture, Forestry, Environment and Water Management and by the Environment Agency Austria. Samples were provided from the Austrian Study of Nutritional Status 2012, which was funded by the former Austrian Federal Ministry of Health. The French human biomonitoring program, of which the ELFE cohort was a component, was funded by the French Ministries of Health and the Environment. ELFE benefited from additional funding from the Ministry of Research, Committee on SHS data (CCDSHS) and Ministry of Culture and Communication (Deps), and as part of the RECONAI platform, from National Research Agency funding (ANR-11-EQPX-0038).